D, T., N, M., GB, C., J, D., S, T., & F, R. (2024). Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells. Frontiers in cell and developmental biology, 12, 1368711. https://doi.org/10.3389/fcell.2024.1368711
Chicago Style (17th ed.) CitationD, Tchelougou, Malaquin N, Cardin GB, Desmul J, Turcotte S, and Rodier F. "Defining Melanoma Combination Therapies That Provide Senolytic Sensitivity in Human Melanoma Cells." Frontiers in Cell and Developmental Biology 12 (2024): 1368711. https://doi.org/10.3389/fcell.2024.1368711.
MLA (9th ed.) CitationD, Tchelougou, et al. "Defining Melanoma Combination Therapies That Provide Senolytic Sensitivity in Human Melanoma Cells." Frontiers in Cell and Developmental Biology, vol. 12, 2024, p. 1368711, https://doi.org/10.3389/fcell.2024.1368711.